NAMS Menopause Certification Exam with Frequently Tested Questions and Verified Answers

NAMS Menopause Certification Exam with Frequently Tested Questions and Verified Answers Which of the following best describes the change in metabolic risk associated with menopause? a. Estrogen decline during menopause has no effect on insulin sensitivity b. Menopause is associated with increased central adiposity and reduced insulin sensitivity c. Menopause decreases visceral fat and improves glucose tolerance d. Menopause eliminates the risk of type 2 diabetes Correct Answer: b. Menopause is associated with increased central adiposity and reduced insulin sensitivity Rationale: The decline in estrogen during menopause is linked to a shift in fat distribution toward visceral (abdominal) adiposity and a reduction in insulin sensitivity, increasing risk for metabolic syndrome and type 2 diabetes. Which mechanism most contributes to increased type 2 diabetes risk after menopause? a. Increased ovarian follicle production b. Decreased hepatic glucose production c. Increased estrogen receptor activity in adipose tissue d. Reduced estrogen leading to impaired insulin signaling Correct Answer: d. Reduced estrogen leading to impaired insulin signaling Rationale: Estrogen has protective effects on glucose metabolism. Its decline impairs insulin signaling pathways and contributes to insulin resistance.